Skip to main content

Table 5 Inequalities in smoking and overweight in European countries between low and high educational groups

From: Socioeconomic inequalities in mortality from conditions amenable to medical interventions: do they reflect inequalities in access or quality of health care?

Country

Smoking*

Overweight

Smoking-related deaths

Alcohol-related deaths

 

OR (CI95)

OR (CI95)

RR (CI95)

RR (CI95)

Western Europe

    

Belgium

1.51 (1.45–1.58)

1.51 (1.45–1.57)

1.72 (1.68–1.77)

1.44 (1.33–1.56)

Switzerland

NA

NA

NA

NA

Nordic countries

    

Sweden

1.26 (1.13–1.40)

0.96 (0.87–1.05)

1.33 (1.31–1.35)

1.78 (1.72–1.84)

Finland

1.29 (1.12–1.36)

1.07 (1.02–1.13)

1.78 (1.73–1.84)

1.67 (1.61–1.74)

Denmark

1.45 (1.35–1.56)

1.25 (1.16–1.34)

1.42 (1.38–1.46)

1.32 (1.25–1.39)

Norway

1.43 (1.25–1.64)

0.95 (0.83–1.09)

1.57 (1.53–1.63)

1.76 (1.65–1.89)

Southern Europe

    

Italy

1.08 (1.05–1.11)

1.51 (1.45–1.57)

1.21 (1.16–1.27)

2.31 (1.63–3.47)

Spain

1.21 (1.13–1.29)

NA

1.43 (1.37–1.49)

1.87 (1.42–2.47)

Baltic region

    

Estonia

1.27 (1.11–1.45)

0.95 (0.83–1.08)

1.64 (1.54–1.74)

1.88 (1.70–2.07)

Lithuania

1.48 (1.35–1.62)

1.03 (0.95–1.08)

2.21 (2.09–2.34)

2.78 (2.53–3.07)

Central and Eastern Europe

    

Slovenia

1.40 (1.09–1.81)

1.11 (0.86–1.42)

1.52 (1.47–1.58)

2.41 (2.26–2.57)

Poland

NA

NA

NA

NA

Czech Republic

1.86 (1.62–2.12)

1.27 (1.12–1.14)

2.41 (2.34–2.47)

2.69 (2.52–2.87)

Hungary

1.88 (1.72–2.05)

1.21 (1.12–1.32)

2.09 (2.04–2.14)

2.27 (2.19–2.33)

  1. *Smoking= current regular smoking and occasional smoking, Overweight=body mass index > 25.
  2. † OR (CI95)=odds ratio with 95% confidence interval adjusted for age and sex.
  3. ‡Smoking related death are chronic obstructive pulmonary disease and cancer of the buccal cavity, pharynx, oesophagus, larynx, trachea, bronchus, and lung.
  4. Alcohol related deaths are accidental poisoning by alcohol and alcoholic psychosis, dependence, abuse, cardiomyopathy, cirrhosis of the liver and inflammation of the pancreas.
  5. For Switzerland and Poland no survey data were available (NA).